Efficacy, Safety, and Tolerability of Zeleciment Rostudirsen (DYNE-251) Administered Intravenously Every 4 Weeks in Ambulatory Participants With Duchenne Muscular Dystrophy (FORZETTO)
Trial details
- Registry ID
- NCT07608432
- Drugs studied
- Zeleciment Rostudirsen (DYNE-251)